Despite clear successes, only a small number of tumor patients currently benefit from molecular profiling. Read here how the CRISPR procedure could change this.
Urinary tract infections are not only a factor that restricts the quality of life of many urological patients but they also significantly increase the risk of stroke, according to a recent study from the USA that makes a special contribution to interdisciplinarity in urology.
Ketogenic diets could modify the immune response and thus change the course of MS. Animal experiments confirm this, but what about humans?
A new software titrates the next insulin dose on the basis of the measured blood sugar patterns and recommends it directly to the patient. The effectiveness of this technological support method was proven in a randomized study.
Increasing global conflicts and climate change are leading to ever-larger migration movements. With these trends, also long-forgotten urological diseases find their way to different parts of the world. Preparations for resurgent diseases cannot wait any longer, as a recent paper in the Journal European Urology shows.
Not even every fourth patient with pulmonary embolism and hemodynamic instability receives systemic lysis. There's still plenty of room for improvement.
An issue sometimes more difficult to treat than the underlying disease: opioid abuse in cancer survivors. Some thoughts and a case report from an oncologist.
Pulmonologists and threshold values - a German topic that is attracting international attention
Not every relationship can withstand the stress test of a serious illness of one of the partners. Studies show that if the woman receives a critical diagnosis, the probability of divorce is six times higher than for sick men.
How many patients see no other way out? A retrospective study on 8.7 million cancer patients currently published in 'Nature' provides answers.
We are all chronically exposed to electromagnetic fields (EMFs). Increasing data on health and environmental impacts is giving rise to increasing debate.
According to a recent Scandinavian cohort study, slightly more amputations and ketoacidosis occur under SGLT2 inhibitors than under GLP1 receptor agonists. Overall, however, the risk of serious adverse events seems manageable.
New research results on Immune-Related Adverse Events (irAEs) of checkpoint inhibitors provided discussion material at the "Palliative and Supportive Care in Oncology Symposium" on November 16-17, 2018 in San Diego.
Glaucoma, diabetic retinopathy and age-related macular degeneration are among the diseases that threaten visual acuity.
Emergency rooms may be often overwhelmed, and in the heat of the moment, it is important to keep a cool head and yet be open to new recommendations that can help us make wise decisions.
Human papillomaviruses play an important role in the development of genital warts and the far more dangerous cervical carcinoma. There are well over 140 different HPV types, of which around 40 can infect the anogenital region.